MGMT and glioblastoma: In glioblastoma, DCA has been reported to enhance the activity of the DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT), thereby increasing the sensitivity of glioblastoma cells to temozolomide, a standard chemotherapeutic agent (Singh et al., 2021).